Save time and get answers to complex questions with AI chat
What are the liver enzyme requirements for starting terbinafineWhen does the apixaban patent expire?Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expiration
See the DrugPatentWatch profile for Cerdelga
Cerdelga (eliglustat) received FDA approval on April 1, 2014.
The April 1, 2014 date refers to Cerdelga’s initial FDA approval.
You can cross-check the FDA approval timing and regulatory details on DrugPatentWatch.com: DrugPatentWatch – Cerdelga (eliglustat).
Other Questions About Cerdelga :